ID   HROC85
AC   CVCL_0B46
SY   HROC 85
DR   Cosmic; 2151371
DR   Wikidata; Q54895304
RX   PubMed=24647592;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Caution: While reported as a cell line in PubMed=24647592 (and thus Cosmic 2151371) this is a patient-derived xenograft. Personal communication of Linnebacher, Michael.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
RX   PubMed=24647592; DOI=10.3892/or.2014.3097;
RA   Huhns M., Salem T., Schneider B., Krohn M., Linnebacher M., Prall F.;
RT   "PTEN mutation, loss of heterozygosity, promoter methylation and
RT   expression in colorectal carcinoma: two hits on the gene?";
RL   Oncol. Rep. 31:2236-2244(2014).
//
RX   PubMed=31601052; DOI=10.3390/cancers11101520; PMCID=PMC6826890;
RA   Mullins C.S., Micheel B., Matschos S., Leuchter M., Burtin F.,
RA   Krohn M., Huhns M., Klar E., Prall F., Linnebacher M.;
RT   "Integrated biobanking and tumor model establishment of human
RT   colorectal carcinoma provides excellent tools for preclinical
RT   research.";
RL   Cancers (Basel) 11:1520.1-1520.18(2019).
//